Free Trial
LON:ABDX

Abingdon Health (ABDX) Share Price, News & Analysis

Abingdon Health logo
GBX 6.52 +0.03 (+0.38%)
As of 08/8/2025 11:08 AM Eastern

About Abingdon Health Stock (LON:ABDX)

Key Stats

Today's Range
6.06
6.54
50-Day Range
6
7.50
52-Week Range
5.50
10.50
Volume
440,182 shs
Average Volume
121,459 shs
Market Capitalization
£12.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ABDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abingdon Health and its competitors with MarketBeat's FREE daily newsletter.

ABDX Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
When Will Abingdon Health Plc (LON:ABDX) Breakeven?
HMG Urgent Care opens in Abingdon
Ballad Health hosts hiring event in Abingdon
See More Headlines

ABDX Stock Analysis - Frequently Asked Questions

Abingdon Health's stock was trading at GBX 7.92 at the beginning of 2025. Since then, ABDX stock has decreased by 17.6% and is now trading at GBX 6.53.

Abingdon Health Plc (LON:ABDX) released its earnings results on Monday, March, 24th. The company reported ($0.53) EPS for the quarter. Abingdon Health had a negative net margin of 20.72% and a negative trailing twelve-month return on equity of 62.56%.

Shares of ABDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abingdon Health investors own include 4D pharma (DDDD), genedrive (GDR), Novacyt (NCYT), Rolls-Royce Holdings plc (RR.L), Tullow Oil (TLW), Active Energy Group (AEG) and B&M European Value Retail (BME).

Company Calendar

Last Earnings
3/24/2025
Today
8/09/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:ABDX
CIK
N/A
Fax
N/A
Employees
84
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.41)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£796.37 thousand
Net Margins
-20.72%
Pretax Margin
N/A
Return on Equity
-62.56%
Return on Assets
-17.93%

Debt

Debt-to-Equity Ratio
46.64
Current Ratio
1.95
Quick Ratio
1.96

Sales & Book Value

Annual Sales
£3.84 million
Price / Sales
3.29
Cash Flow
GBX 2.90 per share
Price / Cash Flow
2.25
Book Value
GBX 0.73 per share
Price / Book
8.97

Miscellaneous

Outstanding Shares
193,631,003
Free Float
N/A
Market Cap
£12.63 million
Optionable
Not Optionable
Beta
0.13
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:ABDX) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners